To explore the molecular mechanisms and shared genetic characteristics of rheumatoid arthritis and cervical cancer based on multiple omics and clinical samples

Rheumatoid arthritis is causally associated with the development of cervical cancer. Patients with rheumatoid arthritis have an increased risk of concurrent cervical cancer. Immune cell pathways, such as NK cell-based, may be important in increasing the risk of cervical cancer in RA patients. The abnormal expression of the model gene may be involved in the progression of cervical cancer patients and the impact of immunotherapy.